Scott Chouinard
Comptroller/Controller/Auditor chez FORRESTER RESEARCH, INC.
Fortune : 147 997 $ au 30/04/2024
Postes actifs de Scott Chouinard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FORRESTER RESEARCH, INC. | Comptroller/Controller/Auditor | 19/11/2009 | - |
| Treasurer | 18/11/2009 | - | |
| Directeur Financier/CFO | 01/04/2021 | 13/09/2021 |
Historique de carrière de Scott Chouinard
Anciens postes connus de Scott Chouinard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Comptroller/Controller/Auditor | - | - |
Formation de Scott Chouinard
| Merrimack College | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Treasurer | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FORRESTER RESEARCH, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Scott Chouinard
- Expérience
